Cikkek nyilvánosan hozzáférhető megbízással - Jaime A. Cardona-OspinaTovábbi információ
Valahol hozzáférhető: 12
Mapping the residual incidence of taeniasis and cysticercosis in Colombia, 2009–2013, using geographical information systems: Implications for public health and travel medicine
AJ Rodríguez-Morales, MC Yepes-Echeverri, WF Acevedo-Mendoza, ...
Travel medicine and infectious disease 22, 51-57, 2018
Megbízások: US National Institutes of Health
Bibliometric analysis of Oropouche research: impact on the surveillance of emerging arboviruses in Latin America
C Culquichicón, JA Cardona-Ospina, AM Patiño-Barbosa, ...
F1000Research 6, 194, 2017
Megbízások: US National Institutes of Health
Massive open online courses in health sciences from Latin American institutions: A need for improvement?
C Culquichicón, LM Helguero-Santin, LM Labán-Seminario, ...
F1000Research 6, 940, 2017
Megbízások: US National Institutes of Health
Laboratory abnormalities in pregnant women with novel coronavirus disease 2019
L Shi, Y Wang, H Yang, G Duan, Y Wang
American journal of perinatology 37 (10), 1070-1073, 2020
Megbízások: National Natural Science Foundation of China
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype
S Bos, AL Graber, JA Cardona-Ospina, EM Duarte, JV Zambrana, ...
Nature Communications 15 (1), 382, 2024
Megbízások: Bill & Melinda Gates Foundation, US National Institutes of Health
Susceptibility to endemic Aedes‐borne viruses among pregnant women in Risaralda, Colombia
JA Cardona-Ospina, AM Trujillo, EV Jiménez-Posada, ...
International Journal of Infectious Diseases 122, 832-840, 2022
Megbízások: US National Institutes of Health
Where are we after 60 years of paragonimiasis research? A bibliometric assessment
C Culquichicón, A Hernández-Pacherres, LM Labán-Seminario, ...
Le infezioni in medicina: rivista periodica di eziologia, epidemiologia …, 2017
Megbízások: US National Institutes of Health
The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior immunity, and assay condition
S Bos, A Graber, JA Cardona-Ospina, E Duarte, JV Zambrana, ...
medRxiv, 2023.06. 20.23291522, 2023
Megbízások: Bill & Melinda Gates Foundation, US National Institutes of Health
Complement-dependent virion lysis mediated by dengue-Zika virus cross-reactive antibodies correlates with protection from severe dengue disease
AG Dias Jr, E Duarte, JV Zambrana, JA Cardona-Ospina, S Bos, V Roy, ...
medRxiv, 2024
Megbízások: Bill & Melinda Gates Foundation
Application of SARS-CoV-2 serology to address public health priorities
AC Sherman, T Smith, Y Zhu, K Taibl, J Howard-Anderson, T Landay, ...
Frontiers in Public Health 9, 744535, 2021
Megbízások: US National Institutes of Health
Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct …
TC Smith, DO Espinoza, Y Zhu, JA Cardona-Ospina, NM Bowman, ...
EBioMedicine 98, 2023
Megbízások: US National Institutes of Health
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype.
A Graber, J Cardona-Ospina, E Duarte, J Zambrana, J Ruíz Salinas, ...
Nature Communications 15 (1), 2024
Megbízások: Bill & Melinda Gates Foundation, US National Institutes of Health
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.